<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36131349</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1465-993X</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Respiratory research</Title><ISOAbbreviation>Respir Res</ISOAbbreviation></Journal><ArticleTitle>Long-term comprehensive cardiopulmonary phenotyping of COVID-19.</ArticleTitle><Pagination><StartPage>263</StartPage><MedlinePgn>263</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">263</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12931-022-02173-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Persistent symptoms after initial COVID-19 infection are common and are frequently referred to by the umbrella terms "post-COVID syndrome" and "long COVID". The sheer number of affected patients pose an increasing challenge to healthcare systems worldwide. To date, our understanding of the pathophysiology of the post-COVID syndrome remains poor and the extent to which persistent cardiopulmonary abnormalities contribute to the symptom complex is unclear. We sought to determine the presence and impact of cardiopulmonary sequelae after COVID-19 in longitudinal assessment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We report on 71 patients who underwent comprehensive, longitudinal testing in regular intervals for up to 12&#xa0;months after their initial COVID-19 diagnosis. Testing included pulmonary function testing, cardiopulmonary exercise testing, dedicated left and right heart echocardiography, lung ultrasonography, and cardiac MRI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our results demonstrate that subjective quality of life after COVID-19 (EQ-5D visual acuity scale, VAS, 67.4 for patients treated as outpatient, 79.2 for patients admitted to the general floor, 71.8 for patients treated in an ICU) is not related to the severity of the initial infection. Maximal exercise capacity is also reduced (VO<sub>2</sub>max 79% predicted, SD&#x2009;&#xb1;&#x2009;19%); however, this is driven in large parts by patients who had initially required ICU-level of care. The degree of objective reduction in exertion did not correlate with quality of life scores. Pulmonary function testing revealed mild and persistent reduction in D<sub>LCO</sub> over the first 12&#xa0;months without significant restrictive or obstructive lung disease. Left and right heart function was intact with good RV function and intact RV/PA coupling, imaging findings suggestive of myocarditis were uncommon (7% of patients).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A reduction in exercise capacity after COVID-19 is common, but is most prominent in patients previously treated in the ICU and more likely related to deconditioning or fatigue than to cardiopulmonary impairment. Subjective quality of life scores are independent of the severity of initial infection and do not correlate with objective measures of cardiopulmonary function. In our cohort, persistent cardiopulmonary impairment after COVID-19 was uncommon. The post-COVID syndrome is unlikely to be the result of cardiopulmonary sequalae and may reflect a post-ICU syndrome in some. Trial registration Registered on clinicaltrials.gov (NCT04442789), Date: June 23, 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kimmig</LastName><ForeName>Lucas M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany. lkimmig@medicine.bsd.uchicago.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Pulmonary and Critical Care, Department of Medicine, The University of Chicago, Chicago, IL, USA. lkimmig@medicine.bsd.uchicago.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rako</LastName><ForeName>Zvonimir A</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Manuel J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G S</LastName><ForeName>Ashkan Tolou</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roller</LastName><ForeName>Fritz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Hospital Giessen, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimminger</LastName><ForeName>Friedrich</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health (ILH), Justus Liebig University Giessen, Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Cluster Cardio-Pulmonary Institute (CPI), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vad&#xe1;sz</LastName><ForeName>Istv&#xe1;n</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health (ILH), Justus Liebig University Giessen, Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Cluster Cardio-Pulmonary Institute (CPI), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeger</LastName><ForeName>Werner</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health (ILH), Justus Liebig University Giessen, Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Cluster Cardio-Pulmonary Institute (CPI), Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Herold</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health (ILH), Justus Liebig University Giessen, Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Cluster Cardio-Pulmonary Institute (CPI), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tello</LastName><ForeName>Khodr</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Matt</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04442789</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>413584448</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>390649896</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Res</MedlineTA><NlmUniqueID>101090633</NlmUniqueID><ISSNLinking>1465-9921</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="Y">Exercise Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary exercise testing</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword></KeywordList><CoiStatement>No competing interests related to this work. Dr. Seeger reports personal fees from Actelion, personal fees from Bayer AG, personal fees from Novartis, personal fees from Vectura, personal fees from Medspray, personal fees from United Therapeutics, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36131349</ArticleId><ArticleId IdType="pmc">PMC9491263</ArticleId><ArticleId IdType="doi">10.1186/s12931-022-02173-9</ArticleId><ArticleId IdType="pii">10.1186/s12931-022-02173-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JHU. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) 2022. https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>WHO. The true death toll of COVID-19 - Estimating global excess mortality: World Health Organization; 2021. https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality.</Citation></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long- term effects of COVID-19: National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP); 2021. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation></Reference><Reference><Citation>Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021; 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021.</Citation></Reference><Reference><Citation>Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21(1):163. doi: 10.1186/s12931-020-01429-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;89:66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur Respir J. 2020;89:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeije R, Caravita S. Phenotyping long COVID. Eur Respir J. 2021;58(2):89. doi: 10.1183/13993003.01763-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01763-2021</ArticleId><ArticleId IdType="pmc">PMC8287735</ArticleId><ArticleId IdType="pubmed">34244323</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, Vidal-Petiot E, et al. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur Respir J. 2021;58(2):9. doi: 10.1183/13993003.01578-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01578-2021</ArticleId><ArticleId IdType="pmc">PMC8361302</ArticleId><ArticleId IdType="pubmed">34385265</ArticleId></ArticleIdList></Reference><Reference><Citation>Skjorten I, Ankerstjerne OAW, Trebinjac D, Bronstad E, Rasch-Halvorsen O, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58(2):78. doi: 10.1183/13993003.00996-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00996-2021</ArticleId><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58(2):78. doi: 10.1183/13993003.00870-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00870-2021</ArticleId><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah SJ, Voduc N, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A, et al. Symptoms, Pulmonary Function, and Functional Capacity Four Months after COVID-19. Ann Am Thorac Soc. 2021;18(11):1912&#x2013;1917. doi: 10.1513/AnnalsATS.202012-1489RL.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202012-1489RL</ArticleId><ArticleId IdType="pmc">PMC8641826</ArticleId><ArticleId IdType="pubmed">33872135</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba GA, Ziehr DR, Rouvina JN, Hariri LP, Knipe RS, Medoff BD, et al. Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. EClinicalMedicine. 2021;39:101066. doi: 10.1016/j.eclinm.2021.101066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101066</ArticleId><ArticleId IdType="pmc">PMC8401400</ArticleId><ArticleId IdType="pubmed">34476393</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinglas VD, Aronson Friedman L, Colantuoni E, Mendez-Tellez PA, Shanholtz CB, Ciesla ND, et al. Muscle Weakness and 5-Year Survival in Acute Respiratory Distress Syndrome Survivors. Crit Care Med. 2017;45(3):446&#x2013;453. doi: 10.1097/CCM.0000000000002208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002208</ArticleId><ArticleId IdType="pmc">PMC5315580</ArticleId><ArticleId IdType="pubmed">28067712</ArticleId></ArticleIdList></Reference><Reference><Citation>Neff TA, Stocker R, Frey HR, Stein S, Russi EW. Long-term assessment of lung function in survivors of severe ARDS. Chest. 2003;123(3):845&#x2013;853. doi: 10.1378/chest.123.3.845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.123.3.845</ArticleId><ArticleId IdType="pubmed">12628887</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Casaer MP, Gunst J, et al. Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study. Intensive Care Med. 2021;47(12):1462&#x2013;1471. doi: 10.1007/s00134-021-06541-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06541-9</ArticleId><ArticleId IdType="pmc">PMC8575347</ArticleId><ArticleId IdType="pubmed">34750648</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293&#x2013;1304. doi: 10.1056/NEJMoa1011802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1011802</ArticleId><ArticleId IdType="pubmed">21470008</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein JR, Laffely NH, Rifkin RD. Quantitative estimation of left ventricular ejection fraction from mitral valve E-point to septal separation and comparison to magnetic resonance imaging. Am J Cardiol. 2006;97(1):137&#x2013;140. doi: 10.1016/j.amjcard.2005.07.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.07.118</ArticleId><ArticleId IdType="pubmed">16377299</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Correction to: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) J Cardiovasc Magn Reson. 2018;20(1):9. doi: 10.1186/s12968-017-0408-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-017-0408-9</ArticleId><ArticleId IdType="pmc">PMC5804075</ArticleId><ArticleId IdType="pubmed">29415744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018;72(24):3158&#x2013;3176. doi: 10.1016/j.jacc.2018.09.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tello K, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, et al. Impaired right ventricular lusitropy is associated with ventilatory inefficiency in pulmonary arterial hypertension. Eur Respir J. 2019;54:5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31515402</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O'Brien K, Sheill G, Dyer AH, O'Kelly B, et al. Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc. 2021;8:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4):2247&#x2013;2261. doi: 10.1378/chest.128.4.2247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.4.2247</ArticleId><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekbom E, Frithiof R, Emilsson &#xd6;, Larson IM, Lipcsey M, Rubertsson S, et al. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med. 2021;182:106394. doi: 10.1016/j.rmed.2021.106394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106394</ArticleId><ArticleId IdType="pmc">PMC8047337</ArticleId><ArticleId IdType="pubmed">33901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez R, Latorre A, Gonzalez-Jimenez P, Feced L, Bouzas L, Yepez K, et al. Reduced Diffusion Capacity in COVID-19 Survivors. Ann Am Thorac Soc. 2021;18(7):1253&#x2013;1255. doi: 10.1513/AnnalsATS.202011-1452RL.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202011-1452RL</ArticleId><ArticleId IdType="pmc">PMC8328367</ArticleId><ArticleId IdType="pubmed">33472019</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Rosso A, Cecchini P, Torrigiani A, Lo Forte A, Carrai P, et al. One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome. Infection. 2022;50(2):513&#x2013;517. doi: 10.1007/s15010-022-01755-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01755-5</ArticleId><ArticleId IdType="pmc">PMC8777423</ArticleId><ArticleId IdType="pubmed">35061232</ArticleId></ArticleIdList></Reference><Reference><Citation>Peixoto AO, Costa RM, Uzun R, Fraga AMA, Ribeiro JD, Marson FAL. Applicability of lung ultrasound in COVID-19 diagnosis and evaluation of the disease progression: A systematic review. Pulmonology. 2021;27(6):529&#x2013;562. doi: 10.1016/j.pulmoe.2021.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2021.02.004</ArticleId><ArticleId IdType="pmc">PMC7983424</ArticleId><ArticleId IdType="pubmed">33931378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravchenko D, Isaak A, Zimmer S, Mesropyan N, Reinert M, Faron A, et al. Cardiac MRI in patients with prolonged cardiorespiratory symptoms after mild to moderate COVID-19. Radiology. 2021;301(3):E419&#x2013;E425. doi: 10.1148/radiol.2021211162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211162</ArticleId><ArticleId IdType="pmc">PMC8369880</ArticleId><ArticleId IdType="pubmed">34374593</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2020;13(11):2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanneman K, Houbois C, Schoffel A, Gustafson D, Iwanochko RM, Wintersperger BJ, et al. Combined cardiac fluorodeoxyglucose-positron emission tomography/magnetic resonance imaging assessment of myocardial injury in patients who recently recovered from COVID-19. JAMA Cardiol. 2022;7(3):298&#x2013;308. doi: 10.1001/jamacardio.2021.5505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.5505</ArticleId><ArticleId IdType="pmc">PMC8756363</ArticleId><ArticleId IdType="pubmed">35019953</ArticleId></ArticleIdList></Reference><Reference><Citation>Agota Szende BJ, Juan C. Self-Reported Population Health: An International Perspective based on EQ-5D. Berlin: Springer; 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">29787044</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J, Sandmann S, Ochs K, Schrempf IM, Frommel C, Dugas M, et al. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci Rep. 2021;11(1):12775. doi: 10.1038/s41598-021-91270-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91270-8</ArticleId><ArticleId IdType="pmc">PMC8211641</ArticleId><ArticleId IdType="pubmed">34140539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Ng AW, Lee LS, Kaw G, Kwek SK, Leow MK, et al. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur Respir J. 2004;24(3):436&#x2013;442. doi: 10.1183/09031936.04.00007104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.04.00007104</ArticleId><ArticleId IdType="pubmed">15358703</ArticleId></ArticleIdList></Reference><Reference><Citation>Benington S, McWilliams D, Eddleston J, Atkinson D. Exercise testing in survivors of intensive care&#x2013;is there a role for cardiopulmonary exercise testing? J Crit Care. 2012;27(1):89&#x2013;94. doi: 10.1016/j.jcrc.2011.07.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2011.07.080</ArticleId><ArticleId IdType="pmc">PMC7125548</ArticleId><ArticleId IdType="pubmed">21958985</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. doi: 10.1016/j.mehy.2020.110055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan PO, Behan WM, Bell EJ. The postviral fatigue syndrome&#x2013;an analysis of the findings in 50 cases. J Infect. 1985;10(3):211&#x2013;222. doi: 10.1016/S0163-4453(85)92488-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-4453(85)92488-0</ArticleId><ArticleId IdType="pubmed">2993423</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>